These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Results of SMANCS/Lipiodol injection therapy for multiple intrahepatic recurrence of hepatocellular carcinoma]. Nakaba H, Hashimoto T, Sunada S, Akamatsu D, Ito A, Teramoto S, Ohara S, Katayama S. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():46-50. PubMed ID: 9512687 [Abstract] [Full Text] [Related]
26. [A case of hepatocellular carcinoma with tumor thrombus in the right atrium successfully treated by arterial administration of lipiodol-SMANCS]. Yamada K, Sato T, Yamada A, Tanaka S, Fujii S, Matuo R, Murata K, Manabe T, Oda J. Gan To Kagaku Ryoho; 1999 Feb; 26(3):361-4. PubMed ID: 10065101 [Abstract] [Full Text] [Related]
27. [Pathologic study of hepatocellular carcinoma treated by TAI and TAE with SMANCS]. Takayasu K, Iwata R, Furukawa T, Nakanishi Y, Sakamoto M. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():70-2. PubMed ID: 9512691 [No Abstract] [Full Text] [Related]
28. [A case of long-term survival with TAE resistant multiple recurrence HCC successfully treated by hepatic resection]. Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Hiramatsu N, Hayashi N, Monden M. Gan To Kagaku Ryoho; 2003 Oct; 30(11):1717-21. PubMed ID: 14619502 [Abstract] [Full Text] [Related]
30. [Arterial infusion of SMANCS for multiple recurrent tumors after hepatic resection]. Takano S, Kono S, Iwai S. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():34-8. PubMed ID: 9512685 [Abstract] [Full Text] [Related]
31. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization. Hirashima N, Sakakibara K, Itazu I, Hirai T, Nemoto A, Matsuura H, Kumada K, Nojiri O, Kano H. Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922 [Abstract] [Full Text] [Related]
32. [Intra-arterial infusion of SMANCS for treatment of patients with hepatocellular carcinoma--adverse reactions and complications]. Sakaguchi T, Yoshimatsu S, Sagara K, Yamashita Y, Takahashi M. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():64-9. PubMed ID: 9512690 [Abstract] [Full Text] [Related]
33. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol]. Konno T. Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275 [Abstract] [Full Text] [Related]
34. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer]. Ikeda K, Saitoh S, Kumada H. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682 [Abstract] [Full Text] [Related]
35. [Arterial infusion chemotherapy with SMANCS]. Nekohashi T, Maruno J, Sanjou A, Toda G. Nihon Rinsho; 2001 Oct; 59 Suppl 6():629-33. PubMed ID: 11762025 [No Abstract] [Full Text] [Related]
39. [A case of massive hepatoma which responded to SMANCS/Lipiodol regimen with intra-arterial infusion]. Kubo M, Fuchigami T, Murata S, Konno T, Maeda H. Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2953-6. PubMed ID: 2551233 [Abstract] [Full Text] [Related]
40. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations]. Nakamura H, Kawata S, Takamura M, Osuga K, Murakami T. Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]